Integra LifeSciences Holdings Corporation
IART
$14.05
-$0.14-0.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 253.61M | 273.30M | 273.57M | 277.60M | 296.93M |
| Total Receivables | 284.51M | 252.45M | 272.37M | 256.13M | 277.78M |
| Inventory | 465.13M | 445.42M | 429.09M | 436.93M | 421.78M |
| Prepaid Expenses | 103.47M | 103.87M | 77.00M | 86.33M | 93.64M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 36.12M | 32.21M | 29.65M | 42.54M | 22.17M |
| Total Current Assets | 1.14B | 1.11B | 1.08B | 1.10B | 1.11B |
|
|
|||||
| Total Current Assets | 1.14B | 1.11B | 1.08B | 1.10B | 1.11B |
| Net Property, Plant & Equipment | 571.39M | 561.38M | 549.77M | 537.25M | 521.04M |
| Long-term Investments | 616.43M | 1.11B | 1.10B | 1.12B | 1.10B |
| Goodwill | 616.43M | 1.11B | 1.10B | 1.12B | 1.10B |
| Total Other Intangibles | 1.19B | 1.19B | 1.21B | 1.21B | 1.22B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 130.68M | 64.27M | 63.14M | 76.49M | 73.14M |
| Total Assets | 3.67B | 4.05B | 4.04B | 4.07B | 4.07B |
|
|
|||||
| Total Accounts Payable | 92.84M | 91.30M | 82.50M | 77.67M | 107.49M |
| Total Accrued Expenses | 180.72M | 187.59M | 169.74M | 178.06M | 170.95M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 628.73M | 627.76M | 622.30M | 616.81M | 39.44M |
| Total Finance Division Other Current Liabilities | 27.52M | 11.81M | 47.59M | 40.03M | 10.44M |
| Total Other Current Liabilities | 27.52M | 11.81M | 47.59M | 40.03M | 10.44M |
| Total Current Liabilities | 929.81M | 918.45M | 922.13M | 912.56M | 328.32M |
|
|
|||||
| Total Current Liabilities | 929.81M | 918.45M | 922.13M | 912.56M | 328.32M |
| Long-Term Debt | 1.23B | 1.23B | 1.20B | 1.21B | 1.80B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 159.27M | 161.48M | 166.93M | 167.81M | 169.56M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 312.44M | 217.09M | 205.93M | 257.07M | 240.02M |
| Total Liabilities | 2.63B | 2.53B | 2.49B | 2.54B | 2.54B |
|
|
|||||
| Common Stock & APIC | 1.33B | 1.32B | 1.32B | 1.32B | 1.30B |
| Retained Earnings | 430.55M | 914.62M | 939.92M | 920.48M | 931.18M |
| Treasury Stock & Other | -720.94M | -714.49M | -718.98M | -716.66M | -699.48M |
| Total Common Equity | 1.04B | 1.52B | 1.55B | 1.52B | 1.53B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.04B | 1.52B | 1.55B | 1.52B | 1.53B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.04B | 1.52B | 1.55B | 1.52B | 1.53B |
|
|
|||||